Longtin v. Organon USA, Inc.
District Court, District of Columbia
1Opinion of the Court
MASTROIANNI, U.S.D.J.
I. INTRODUCTION
Cali Longtin ("Plaintiff") brings this action against Organon USA, Inc., N.V. Organon, Schering Corp., Merck & Co., Inc., and Merck Sharp & Dohme ("Defendants"), for claims related to a stroke she suffered in New Jersey following her use of NuvaRing, a prescription contraceptive.1 Presently before the court is Defendants' motion for summary judgment as to all counts. (Dkt. No. 90.) For the following reasons, the court will grant Defendants' motion.
II. BACKGROUND AND PROCEDURAL HISTORY
The following facts, which are construed in a light most favorable to…
2Cases cited25 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Samuel Mesnick v. General Electric CompanyCourt of Appeals for the First Circuit · 1991
- Bushkin Associates, Inc. v. Raytheon Co.Massachusetts Supreme Judicial Court · 1985
- Perez v. Wyeth Laboratories Inc.Supreme Court of New Jersey · 1999
20 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Luna v. Atrium Medical CorporationDistrict Court, D. New Hampshire · 2019
- Sampel v. Whole Foods Market Group, Inc.District Court, D. Massachusetts · 2020